New Jersey will pay about $53 million in a settlement following claims that the state's negligence contributed to the COVID deaths of more than 100 veterans in state-run facilities.
TRENTON, N.J. — New Jersey will pay about $53 million over COVID deaths at its veterans’ homes. The settlement follows claims that the state’s negligence contributed to the deaths of more than 100 veterans in state-run facilities.
New Jersey Gov. Phil Murphy came under criticism in the early days of the pandemic in 2020 after directing veterans’ homes not to turn away patients who had tested positive.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
L.A. County Reports 7 New Covid-19 Deaths And 8,891 New Positive CasesSUNDAY: The Los Angeles County Department of Public Health reported 7 new deaths from Covid-19, as well as 8,891 new positive cases. The number of deaths and confirmed cases reported today may refl…
Baca lebih lajut »
New easy-to-use COVID-19 pills come with a catchNewly infected COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear.
Baca lebih lajut »
Florida Has Record High Number Of New Covid-19 Coronavirus CasesThings have changed since October 27, when the Office of Florida Governor Ron DeSantis issued a press release with the headline, “Florida Reaches Lowest Case Rate in the Nation?”
Baca lebih lajut »
A Pediatric Disease Expert Weighs In On The New Inflammatory Condition Linked To COVID-19The condition, which causes inflammatory symptoms in children—such as fever, rash, swollen lymph nodes, stomach pain, and heart issues—has been linked to COVID-19; most children who have it either tested positive for the virus, or positive for antibodies.
Baca lebih lajut »
New easy-to-use COVID-19 pills come with a catchThe antiviral pills aren’t for everyone who gets a positive test. The pills are intended for those with mild or moderate COVID-19 who are more likely to become seriously ill.
Baca lebih lajut »